← Back to Clinical Trials
Recruiting NCT06833632
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Trial Parameters
Condition Non-Small-Cell Lung Cancer
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-05-25
Completion 2025-09-11
Brief Summary
The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia
Eligibility Criteria
Inclusion Criteria: * obtaining voluntary written informed consent * diagnosis of NSCLC * clinical stage I-IIA cN0 * Candidates for surgical resection Exclusion Criteria: * Pregnancy * Induction therapy for pulmonary neoplasia * Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery * Any previous surgery for lung cancer * Patients with other active neoplasms * Infiltration of the chest wall
Related Trials
NCT06476093
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
View Trial →
NCT06272864
BostonGene and Exigent Genomic INsight Study
View Trial →
NCT06809764
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m N
View Trial →